Patient
P2B-058
withdrawn Phase IIA Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · State Health Centre Oncology Department (Budapest, Hungary) (Dr. Clarke)
consented 2012-12-08
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 4
Grade 2 nausea with onset in cycle 2 (2013-01-18); assessed as not related to study drug (not related); resolved 2013-01-20.
Grade 2 alopecia with onset in cycle 1 (2013-01-15); assessed as related to study drug (probable); not resolved at last follow-up.
Grade 2 stomatitis with onset in cycle 1 (2013-01-04); assessed as related to study drug (probable); resolved 2013-01-13.
Grade 1 vomiting with onset in cycle 1 (2012-12-26); assessed as not related to study drug (unlikely); resolved 2012-12-28.
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.